Hyperlipidaemia and International normalised ratio decreased

Summary:

International normalised ratio decreased is found among people with Hyperlipidaemia, especially for people who are male, 60+ old.

The study analyzes which people have International normalised ratio decreased with Hyperlipidaemia. It is created by eHealthMe based on reports of 20 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,422 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is International normalised ratio decreased?

International normalised ratio decreased is found to be associated with 511 drugs and 763 conditions by eHealthMe. Check the latest studies of International normalised ratio decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

20 people who have Hyperlipidaemia and International Normalised Ratio Decreased are studied.

Would you have International normalised ratio decreased when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced International Normalised Ratio Decreased *:

female: 42.11 %
male: 57.89 %

Age of people who have Hyperlipidaemia and experienced International Normalised Ratio Decreased *:

Common co-existing conditions for these people *:

High Blood Pressure: 9 people, 45.00%
Type 2 Diabetes: 2 people, 10.00%
Cardiac Disorder: 2 people, 10.00%
Cardiac Failure Chronic: 2 people, 10.00%
Diabetes: 2 people, 10.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 10.00%
Insomnia (sleeplessness): 1 person, 5.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
Cardiomyopathy (weakening of the heart muscle): 1 person, 5.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 25.00%
Haemoglobin Decreased: 5 people, 25.00%
Alanine Aminotransferase Increased: 4 people, 20.00%
Hyperkalemia (damage to or disease of the kidney): 4 people, 20.00%
Haematocrit Decreased: 4 people, 20.00%
Activated Partial Thromboplastin Time Prolonged: 3 people, 15.00%
Constipation: 3 people, 15.00%
Hypotension (abnormally low blood pressure): 3 people, 15.00%
High Blood Pressure: 3 people, 15.00%
High Blood Cholesterol: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have International normalised ratio decreased?

- Check whether International normalised ratio decreased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hyperlipidaemia (86,394 reports)
International normalised ratio decreased (6,149 reports)

All the drugs that are associated with International normalised ratio decreased:

International normalised ratio decreased (511 drugs)

All the conditions that are associated with International normalised ratio decreased:

International normalised ratio decreased (763 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on International normalised ratio decreased and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.